Literature DB >> 29342385

Ovarian Cancer Treatment - Are We Getting Warmer?

David R Spriggs1, Oliver Zivanovic1.   

Abstract

Mesh：

Year:  2018        PMID： 29342385     DOI： 10.1056/NEJMe1714556

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Hyperthermic Intraperitoneal Chemotherapy in the Treatment Armamentarium of Epithelial Ovarian Cancer: Time to End the Dichotomy.

Authors:  Aditi Bhatt; Olivier Glehen
Journal:  Visc Med       Date:  2022-01-10

2.  Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer.

Authors:  Na Li; Xianquan Zhan
Journal:  EPMA J       Date:  2019-07-19       Impact factor: 6.543

Review 3.  Targeting cancer stem cells in drug discovery: Current state and future perspectives.

Authors:  Fang-Yu Du; Qi-Fan Zhou; Wen-Jiao Sun; Guo-Liang Chen
Journal:  World J Stem Cells       Date:  2019-07-26       Impact factor: 5.326

Review 4.  First-Line Management of Advanced High-Grade Serous Ovarian Cancer.

Authors:  Reem D Mahmood; Robert D Morgan; Richard J Edmondson; Andrew R Clamp; Gordon C Jayson
Journal:  Curr Oncol Rep       Date:  2020-06-04       Impact factor: 5.075

5.  A DM1-doped porous gold nanoshell system for NIR accelerated redox-responsive release and triple modal imaging guided photothermal synergistic chemotherapy.

Authors:  Pengcheng Xu; Ru Wang; Wenqian Yang; Yanyan Liu; Dongsheng He; Zixuan Ye; Daquan Chen; Yuan Ding; Jiasheng Tu; Yan Shen
Journal:  J Nanobiotechnology       Date:  2021-03-19       Impact factor: 10.435

Review 6.  Hyperthermic intraperitoneal chemotherapy in ovarian cancer: Qui Bono?

Authors:  John Spiliotis
Journal:  Ann Transl Med       Date:  2020-12

Review 7.  Recent Advances of Magnetic Nanomaterials in the Field of Oncology.

Authors:  Tianyang Li; Chunsheng Yang; Zhiping Wei; Dongsheng Pei; Guan Jiang
Journal:  Onco Targets Ther       Date:  2020-05-28       Impact factor: 4.147
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.